Grant: Master's Award: Canada Graduate Scholarships
McGill University
$17,500.00
Blocking the Interaction between Nck1 and PERK: a Novel Approach to Generate Robust Pancreatic Beta Cells
FY 2015-16
Summary
Introduction Beta cells in the pancreas make and release insulin, a hormone involved in maintaining healthy glucose levels in the blood. When people develop diabetes, they have trouble producing insulin due to beta cell dysfunction. Some people that develop diabetes early in life do so because they have a non-functional PERK, an essential protein for beta cells to produce insulin.Objective Recently, our group has reported that another protein, named Nck1, interacts with PERK and limits PERK activity. In addition, we have shown that Nck1 counteracts PERK’s beneficial effects on beta cells’ ability to produce insulin and to survive under conditions of diabetes-related stress. The objective of my project is to engineer robust beta cells with a greater capacity to produce insulin and to resist diabetes-related stress by preventing the interaction between Nck1 and PERK.Methods As we have identified how Nck1 and PERK interact, we have designed a compound that has the potential to specifically inhibit this interaction. Therefore, I plan to achieve my objective of creating robust beta cells by showing that treatment with this compound improves beta cell function and health. Significance Diabetes, one of the most common metabolic diseases in the world, is characterized by the inability of pancreatic beta cells to produce sufficient amounts of insulin. There is currently no powerful therapy to improve beta cell function or to protect beta cells in people with high risk of developing diabetes. Results from my experiments will provide new opportunities for the development of therapies to prevent and treat this disease.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
350130
Name
Kefalas George
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Blocking the Interaction between Nck1 and PERK: a Novel Approach to Generate Robust Pancreatic Beta Cells
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Adaptor Proteins; Diabetes; Insulin Biosynthesis; Metabolic Disease; Pancreatic Islets; Unfolded Protein Response
Abstract
Introduction Beta cells in the pancreas make and release insulin, a hormone involved in maintaining healthy glucose levels in the blood. When people develop diabetes, they have trouble producing insulin due to beta cell dysfunction. Some people that develop diabetes early in life do so because they have a non-functional PERK, an essential protein for beta cells to produce insulin.Objective Recently, our group has reported that another protein, named Nck1, interacts with PERK and limits PERK activity. In addition, we have shown that Nck1 counteracts PERK’s beneficial effects on beta cells’ ability to produce insulin and to survive under conditions of diabetes-related stress. The objective of my project is to engineer robust beta cells with a greater capacity to produce insulin and to resist diabetes-related stress by preventing the interaction between Nck1 and PERK.Methods As we have identified how Nck1 and PERK interact, we have designed a compound that has the potential to specifically inhibit this interaction. Therefore, I plan to achieve my objective of creating robust beta cells by showing that treatment with this compound improves beta cell function and health. Significance Diabetes, one of the most common metabolic diseases in the world, is characterized by the inability of pancreatic beta cells to produce sufficient amounts of insulin. There is currently no powerful therapy to improve beta cell function or to protect beta cells in people with high risk of developing diabetes. Results from my experiments will provide new opportunities for the development of therapies to prevent and treat this disease.
Competitiondate
201512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Kefalas, George
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~